Results 101 to 110 of about 36,016 (212)

Adefovir dipivoxil alone or in combination with lamivudine for three months in patients with lamivudine resistant compensated chronic hepatitis B

, 2007
We studied clinical and laboratory effects of 3 months of lamivudine with adefovir combination and adefovir dipivoxil (AD) alone in the treatment of patients with lamivudine-resistant hepatitis B virus (HBV) infection.
Gunsar, Fulya, Ersoz, Galip, Akarca, Ulus, Ilter, Tankut, Akyildiz, Murat, Batur, Yucel, Karasu, Zeki   +6 more
core   +1 more source

Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study)

, 2006
Objective: We compared the immunological and clinical outcomes of lamivudine monotherapy and complete therapy interruption in the treatment of HIV-1-infected patients harbouring lamivudine-resistant virus.
CLEMENTI, MASSIMO, Boeri, E, Galli, A, Galli, L, Gianotti, N, Cernuschi, M, CASTAGNA, ANTONELLA, Hasson, H, LAZZARIN, ADRIANO, Menzo, S, Carini, E, Danise, A   +11 more
core   +1 more source

A facile and effective synthesis of lamivudine 5'-diphosphate

, 2011
International audienceWe report on the first solution synthesis of lamivudine 5'-diphosphate in both high yield and purity. Efficient synthesis of lamivudine 5'-monophosphate was obtained through lamivudine H-phosphonate oxydation by (-)-(8,8 ...
Lefebvre, Isabelle, Puy, Jean-Yves, Perigaud, Christian, Roy, Béatrice   +3 more
core   +1 more source

Lamivudine-induced red cell aplasia

, 2008
Anaemia is frequent in patients with human immunodeficiency virus infection, and antiretroviral drugs have been implicated. Whilst therapy-induced anaemia is more readily attributed to zidovudine, lamivudine-associated, potentially life-threatening, pure
Grobusch, Martin P., John, Melanie-Anne A., Menezes, Colin N., Rhemtula, Yasin A.   +3 more
core   +1 more source

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens

, 2010
Background During stavudine phase-out plan in developing countries, tenofovir is used to substitute stavudine. However, knowledge regarding whether there is any difference of the frequency of renal injury between tenofovir/lamivudine/efavirenz and ...
Lueangniyomkul Aroon, Aroon Lueangniyomkul, Tantanathip Preecha, Anongnuch Narkksoksung, Mankatitham Wiroj, Sungkanuparph Somnuek, Somnuek Sungkanuparph, Samruay Nilkamhang, Nilkamhang Samruay, Wiroj Mankatitham, Prasithsirikul Wisit, Manosuthi Weerawat, Weerawat Manosuthi, Preecha Tantanathip, Suntisuklappon Busakorn, Busakorn Suntisuklappon, Wisit Prasithsirikul, Narkksoksung Anongnuch   +17 more
core   +1 more source

Incidence and determinants of excessive weight gain in people living with HIV initiating tenofovir, lamivudine, and dolutegravir-based therapy: a multicenter retrospective study in northwest Ethiopia

Frontiers in Pharmacology
BackgroundThe incidence and nature of excessive weight gain associated with antiretroviral treatment using tenofovir, lamivudine, and dolutegravir based regimens among patients living with human immunodeficiency virus has not been properly examined in ...
Gashaw Sisay Chanie, Wagaye Atalay, Tirsit Ketsela Zeleke, Zemenu Wube Bayleyegn, Yonas Sisay Aragie, Gizachew Kassahun Bizuneh, Mihret Melese, Rahel Belete Abebe   +7 more
doaj   +1 more source

Lamivudine therapy for chronic hepatitis B

, 2010
Lamivudine was introduced as an antiviral for chronic hepatitis B over a decade ago. Its role in the management of CHB has been constantly changing. Lamivudine has proven benefit in both hepatitis B e antigen‐positive and ‐negative patients.
Fung, J, Yuen, RMF, Lai, CL, Seto, WK
core  

Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa

Brazilian Journal of Infectious Diseases
The coinfection of HIV and hepatitis B virus (HBV) and their vertical transmission constitute a public health problem in sub-Saharan countries of Africa.
Denise Ilboudo, Jacques Simpore, Djeneba Ouermi, Cyrille Bisseye, Tani Sagna, Silvia Odolini, Fabio Buelli, Virginio Pietra, Salvatore Pignatelli, Charlemagne Gnoula, Jean-Baptiste Nikiema, Salvatore Musumeci   +11 more
doaj   +1 more source

De novo combination therapy adefovir plus lamivudine as a treatment for women of child-bearing age with HBeAg-positive chronic hepatitis B before pregnancy

, 2014
Substantial progress has been achieved in antiviral therapy for chronic hepatitis B; however, options for women of child-bearing age with HBeAg-positive chronic hepatitis B remain a challenge.
Liu, Shuai-Wei, Xie, Yan, Liu, Xiao-Yan, Ding, Xiang-Chun, Xu, Chun-Qiong, Ma, Li-Na   +5 more
core   +1 more source

Immunovirological treatment out- comes after 2 years of antiretroviral therapy in children living with the human immune deficiency virus in Lagos Nigeria

Nigerian Journal of Paediatrics
Background/objective: The World Health Organization (WHO) recommends routine assessment of antiretroviral treatment outcomes to detect treatment failure early and prevent the development of drug resistance. The aim of this study was to describe treatment
Nwaiwu O, Akindele AJ, Akanmu AS, Adeyemi OO   +3 more
doaj